On March 29, 2010, the University of Utah and Myriad Genetics Inc. lost a U.S. court ruling over some of its patents for detecting inherited breast cancer related to the genes BRCA1 and BRCA2. The 152-page decision, which addresses questions about whether human genes should be subject to patent protection, could have major ramifications for […]